Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea

Rosacea, Papulopustular Clinical Trial

Official title: Azelaic Acid Foam 15% in the Treatment of Papulopustula Rosacea: An Evaluation of Photographic Evidence

Status Completed

Clinical Trial Summary

This research study is being performed to evaluate the photographic evidence of the efficacy and tolerability of Azelaic Acid Foam 15% in the treatment of papulopustular rosacea.

Clinical Trial Description

This is a single site, single arm open label study of Azelaic Acid foam 15% for the treatment of moderate to severe papulopustular rosacea. All patients will apply Azelaic Acid foam twice daily. At scheduled visits, high resolution equipment will be used to measure 3D topographical values for elevation of papules and pustules to objectively evaluate reduction of papulopustular lesions. Investigator and subject assessments will also be completed to assess the level of rosacea at weeks 4,8 and 12. ;

Related Conditions & MeSH terms

• Rosacea
• Rosacea, Papulopustular

• NCT number: NCT03418610
• Study type: Interventional
• Source: Clinical Research Center of the Carolinas
• Status: Completed
• Phase: Phase 4
• Start date: December 6, 2017
• Completion date: January 9, 2019